Back to Trades
SAXE JON S
DirectorCIK 0001114914
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
SAXE JON S, Director, accounts for 1 disclosed filing worth $63.5K, all concentrated in Vistagen Therapeutics, Inc. (VTGN), active 2025. Data is sourced from official SEC Form 3, 4, and 5 filings.